Naoki Kitamura

GMO Gamepot, Inc. develops and distributes online games and mobile content business. Its operations are carried out through the following business divisions: Online Game Business and Mobile Content Business. The Online Games Business division provides online game distribution and corporate game services. The Mobile Content Business division provides the planning and management of entertainment content for mobile end users. The company was founded on May 17, 2001 and is headquartered in Tokyo, Japan.

Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX.

Part of H.U. Group Holdings, Inc., Baylor Miraca Genetics Laboratories LLC is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including whole genome sequencing, whole exome sequencing, and focused panels. The company is based in Houston, TX, located in the Texas Medical Center, and serves clients in 50 states and 16 countries. Baylor Genetics specializes in clinically relevant genetic testing and helps determine an individual’s chance of developing or passing on a genetic disorder. Baylor Genetics excels in the field of genetics and precision medicine. Baylor Miraca Genetics Laboratories was acquired by Miraca USA, Inc. from Baylor College of Medicine on February 02, 2015 for $138 million.

SRL, Inc. provides clinical laboratory testing services. The company supports clinical testing for every aspect of the modern medical care for disease diagnoses, elucidation of pathology, determination of treatment plans, monitoring of post-treatment prognosis, health check-ups. It also engages in the health check-up management and health promotion services; clinical trails; pharmaceutical development; hospital cleaning services and others. The company was founded on June 16, 1970 and is headquartered in Tokyo, Japan.

Part of H.U. Group Holdings, Inc., Fujirebio Holdings, Inc. is a Japanese company that develops diagnostic products for neurodegenerative diseases. The company is based in Tokyo, Japan. The company was founded in 2017. Goki Ishikawa has been the CEO of the company since 2017.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.